FDA has released a proposed rule to govern “gluten-free” labeling on food products. Congress required FDA to begin rulemaking on the issue of “gluten-free” claims as part of the Food Allergen Labeling and Consumer Protection Act of 2004 (“FALCPA”). FALCPA directed FDA to issue its proposed rule by August 2006 with a final rule to be implemented no later than August 2008.
The proposed rule will be published in the Federal Register on January 23 and the comment period will be open for 90 days.
If you would like additional information, please contact a Food Industry Team representative or visit the FDA’s Web site.
People
Related News
16 May 2025
In the News
Foley's East Coast Litigation Additions Highlighted in Legal Press
Foley & Lardner LLP partners Kenneth Breen, Phara Guberman, and Joseph Dowdy are featured across legal press for their recent move to the firm.
16 May 2025
In the News
Foley Attorneys Assess AI Use in Clinical Trials
Foley & Lardner LLP partners Monica Chmielewski and Kyle Faget shared insights on the growing adoption of artificial intelligence in clinical trials in the Clinical Trials Arena article, "Are regulators keeping pace with AI adoption in clinical trials?"
15 May 2025
In the News
Grace Fucci Publishes on Sustainability in Luxury Fashion
Foley & Lardner LLP associate Grace Fucci explores the intersection of luxury fashion and sustainability in The Global Legal Post article, "Can luxury fashion houses join the sustainability discussion?"